All In MedTech

Company

CONMED

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

CONMED is on our public-company list (ticker CNMD). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

CNMD

NYSE · CONMED Corp

Public float

$1.20B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$1.37B

Fiscal year ending Dec 31, 2025

Net income

$47.1M

Fiscal year ending Dec 31, 2025

R&D spending

$55.9M

Fiscal year ending Dec 31, 2025

Cash

$48.0M

As of Sep 30, 2026

Long-term debt

$636M

As of Sep 30, 2026

Shares outstanding

29.8M

As of Oct 26, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2022–––$800M

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For CONMED we have 3 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

The 8 newest of 55 since 2015.

Search the Clearance Tracker

52 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

1 more trials with a free account

Reports received

673

Received Nov 1, 2025 to Nov 20, 2026. Includes 3 of another or unstated type.

Malfunction reports

536

80% of reports

Injury reports

129

19% of reports

Death reports

5

0.7% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2322200
Jan 2433200
Feb 2437700
Mar 2425200
Apr 2426401
May 2433100
Jun 2427700
Jul 2424401
Aug 2429600
Sep 2437700
Oct 2434700
Nov 24241000
Dec 2440100
Jan 2529600
Feb 25291400
Mar 2519500
Apr 2527600
May 2525300
Jun 2531801
Jul 2523600
Aug 259700
Sep 2522200
Oct 2516400
Nov 2535300
Dec 25551320
Jan 2649800
Feb 2635810
Mar 26821000
Apr 26271301
May 26351310
Jun 26601910
Jul 2632801
Aug 26381601
Sep 2647800
Oct 26411000
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

285 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.